Skip to main content
Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · IEX Real-Time Price · USD
13.60
-0.14 (-1.02%)
May 2, 2024, 1:08 PM EDT - Market open

Bausch + Lomb Revenue

Bausch + Lomb had revenue of $4.31B in the twelve months ending March 31, 2024, with 13.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.10B with 18.05% year-over-year growth. In the year 2023, Bausch + Lomb had annual revenue of $4.15B with 10.03% growth.

Revenue (ttm)
$4.31B
Revenue Growth
+13.23%
P/S Ratio
1.09
Revenue / Employee
$324,361
Employees
13,300
Market Cap
4.77B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.15B378.00M10.03%
Dec 31, 20223.77B3.00M0.08%
Dec 31, 20213.77B353.00M10.35%
Dec 31, 20203.41B-366.00M-9.69%
Dec 31, 20193.78B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
Organon & Co. 6.26B
Option Care Health 4.43B
R1 RCM 2.25B
Halozyme Therapeutics 829.25M
Apellis Pharmaceuticals 396.59M
Glaukos 314.71M
Blueprint Medicines 249.38M
Revenue Rankings

BLCO News

More News